Table 1.
Clinical and total RNA characteristics of SARS-CoV-2 patients and controls included in the study.
| Group 1 (Covid-19 positive, persistent olfactory symptoms) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | Age | Sex | Positive test date | Olfactory test date | Olfactory test score | OE sampling date | Total RNA (μg) | A260/280 | A260/230 | R.I.N. | |
| P11 | 20 | Female | 2020-11-26 | 2021-03-29 | 14 | 2021-03-29 | 6.73 | 2.13 | 1.99 | 8.8 | |
| P12 | 62 | Male | 2020-03-27 | 2021-03-29 | 25.5 | 2021-03-29 | 6.68 | 2.12 | 1.42 | 8.4 | |
| P14 | 41 | Female | 2020-03-19 | 2021-03-29 | 27 | 2021-03-29 | 5.64 | 2.13 | 2.18 | 8.2 | |
| P16 | 22 | Male | 2020-11-01 | 2021-04-19 | 9 | 2021-04-19 | 5.13 | 2.11 | 2.22 | 8.6 | |
| P17 | 26 | Female | 2020-11-28 | 2021-04-19 | 29 | 2021-04-19 | 8.83 | 2.12 | 2.12 | 9.4 | |
| P21 | 48 | Female | 2020-03-16 | 2021-05-10 | 26 | 2021-05-10 | 2.05 | 2.12 | 2.18 | 7.3 | |
| Group 2 (Covid-19 positive, full recovery from olfactory symptoms) | |||||||||||
| Code | Age | Sex | Positive test date | Olfactory test date | Olfactory test score | OE sampling date | Total RNA (μg) | A260/280 | A260/230 | R.I.N. | |
| P4 | 28 | Male | 2020-10-09 | 2021-03-15 | 32.25 | 2021-03-15 | 2.15 | 2.19 | 1.32 | 6.4 | |
| P5 | 59 | Female | 2020-10-10 | 2021-03-22 | 35.25 | 2021-03-22 | 7.06 | 2.14 | 2.15 | 6.8 | |
| P18 | 28 | Male | 2020-03-04 | 2021-04-26 | 35.75 | 2021-04-26 | 6.76 | 2.13 | 1.96 | 8.3 | |
| P23 | 27 | Male | 2020-03-22 | 2021-05-24 | 37.75 | 2021-05-24 | 14.29 | 2.11 | 2.13 | 6.7 | |
| P25 | 59 | Female | 2020-03-21 | 2021-05-31 | 35.5 | 2021-05-31 | 11.82 | 2.11 | 2.2 | 6.5 | |
| Group 3 (Covid-19 positive, no olfactory symptoms) | |||||||||||
| Code | Age | Sex | Positive test date | Olfactory test date | Olfactory test score | OE sampling date | Total RNA (μg) | A260/280 | A260/230 | R.I.N. | |
| P6 | 26 | Female | 2020-11-11 | 2021-03-22 | 34.5 | 2021-03-22 | 6.29 | 2.14 | 2.18 | 6.5 | |
| P7 | 23 | Female | 2020-09-30 | 2021-03-22 | 30.5 | 2021-03-22 | 5.80 | 2.16 | 1.43 | 7.1 | |
| P9 | 37 | Female | 2020-11-03 | 2021-03-22 | 32.5 | 2021-03-22 | 7.04 | 2.14 | 2.05 | 7.3 | |
| P8 | 48 | Male | 2020-03-14 | 2021-03-22 | 35.5 | 2021-03-22 | 6.17 | 2.14 | 2.09 | 6.7 | |
| P22 | 31 | Female | 2020-10-30 | 2020-05-10 | 35.5 | 2021-05-10 | 2.37 | 2.12 | 2.38 | 7.3 | |
| Group 4 (Covid-19 negative, healthy) | |||||||||||
| Code | Age | Sex | Positive test date | Olfactory test date | Olfactory test score | OE sampling date | Total RNA (μg) | A260/280 | A260/230 | R.I.N. | |
| C5 | 25 | Male | 2021-03-29 | 32.5 | 2021-03-29 | 4.87 | 2.14 | 2.2 | 6.0 | ||
| C6 | 27 | Male | 2021-03-29 | 30.5 | 2021-03-29 | 4.67 | 2.12 | 2.19 | 8.0 | ||
| C9 | 28 | Male | 2021-05-10 | 40 | 2021-05-10 | 12.53 | 2.13 | 2.46 | 6.0 | ||
| C10 | 30 | Female | 2021-06-14 | 37,5 | 2021-06-14 | 3.44 | 2.11 | 1.83 | 6.0 | ||
| C11 | 27 | Male | 2021-06-14 | 43.75 | 2021-06-14 | 2.88 | 2.11 | 2.12 | 6.7 | ||
The olfactory test score represents functional anosmia (score 0-15), hyposmia (score 15-30), normosmia (score 30-45). R.I.N. (RNA integrity number) ranges from 1 (RNA completely degraded) to 10 (best quality RNA).